Media-OutReach Newswire Immuno Cure’s Anti-Δ42PD1 Antibody Project Awarded HKSAR Government’s RAISe+ Scheme Funding
Media-OutReach Newswire Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics
Media-OutReach Newswire PolyU Study: Close to 90% of C-Section Babies Experience Illness Before the Age of 1 Scholars Recommend Continued Breastfeeding